Synthesis question: Several vaccines against viral infections are made by isolating purified surface proteins of the viral particle, mixing them with an adjuvant to stimulate an innate immune response, and injecting the mixture into people. Two examples of this are the vaccine against Hepatitis B virus, and the vaccine against Human Papilloma Virus (the 'cervical cancer' vaccine). One interesting property of vaccines of this type (known as 'subunit vaccines') is that there is a requirement for a CD4 T cell response to the vaccine antigen in order to generate antibodies to the innocuous protein in the vaccine. In the case of the Hepatitis B vaccine, the viral protein included in the vaccine is the Hepatitis B surface antigen (HepB-SAg), a protein that is approximately 200 amino acids in length. The graph in Figure shows the data from immunizing individuals with this vaccine, and monitoring their production of protective antibody responses to the viral protein.
a) What results would be predicted if experiments were performed to examine the CD4 T cell responses to the HepB-SAg in these same individuals? In particular, indicate whether all individuals would show similar responses. Explain your reasoning.
b) Most vaccines, particularly those made by immunizing individuals with purified pathogen components, are designed to elicit robust antibody responses to the immunizing antigens. For vaccines against viral infections (like the HepB vaccine), the immune responses generated are only protective when administered prophylactically, i.e., before the individual is ever exposed to the pathogen. Why is it essential to vaccinate against viral infections before the individual is ever exposed to the virus?

Question

Synthesis question: Several vaccines against viral infections are made by isolating purified surface proteins of the viral particle, mixing them with an adjuvant to stimulate an innate immune response, and injecting the mixture into people. Two examples of this are the vaccine against Hepatitis B virus, and the vaccine against Human Papilloma Virus (the 'cervical cancer' vaccine). One interesting property of vaccines of this type (known as 'subunit vaccines') is that there is a requirement for a CD4 T cell response to the vaccine antigen in order to generate antibodies to the innocuous protein in the vaccine. In the case of the Hepatitis B vaccine, the viral protein included in the vaccine is the Hepatitis B surface antigen (HepB-SAg), a protein that is approximately 200 amino acids in length. The graph in Figure  shows the data from immunizing individuals with this vaccine, and monitoring their production of protective antibody responses to the viral protein. 
a) What results would be predicted if experiments were performed to examine the CD4 T cell responses to the HepB-SAg in these same individuals? In particular, indicate whether all individuals would show similar responses. Explain your reasoning. 
b) Most vaccines, particularly those made by immunizing individuals with purified pathogen components, are designed to elicit robust antibody responses to the immunizing antigens. For vaccines against viral infections (like the HepB vaccine), the immune responses generated are only protective when administered prophylactically, i.e., before the individual is ever exposed to the pathogen. Why is it essential to vaccinate against viral infections before the individual is ever exposed to the virus?

Quizplus · Accepted Answer

The Answer of Synthesis question: Several vaccines against viral infections are made by isolating purified surface proteins of the viral particle, mixing them with an adjuvant to stimulate an innate immune response, and injecting the mixture into people. Two examples of this are the vaccine against Hepatitis B virus, and the vaccine against Human Papilloma Virus (the 'cervical cancer' vaccine). One interesting property of vaccines of this type (known as 'subunit vaccines') is that there is a requirement for a CD4 T cell response to the vaccine antigen in order to generate antibodies to the innocuous protein in the vaccine. In the case of the Hepatitis B vaccine, the viral protein included in the vaccine is the Hepatitis B surface antigen (HepB-SAg), a protein that is approximately 200 amino acids in length. The graph in Figure  shows the data from immunizing individuals with this vaccine, and monitoring their production of protective antibody responses to the viral protein. 
a) What results would be predicted if experiments were performed to examine the CD4 T cell responses to the HepB-SAg in these same individuals? In particular, indicate whether all individuals would show similar responses. Explain your reasoning. 
b) Most vaccines, particularly those made by immunizing individuals with purified pathogen components, are designed to elicit robust antibody responses to the immunizing antigens. For vaccines against viral infections (like the HepB vaccine), the immune responses generated are only protective when administered prophylactically, i.e., before the individual is ever exposed to the pathogen. Why is it essential to vaccinate against viral infections before the individual is ever exposed to the virus?

Synthesis Question: Several Vaccines Against Viral Infections Are Made by Isolating